Federated Hermes, Inc. Nautilus Biotechnology, Inc. Transaction History

Federated Hermes, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 31, 2024	BUY	$2.34 - $3.39 $858 - $1,244	367 Added 4.02%	9,500 $28,000
Q3 2023 Nov 13, 2023	BUY	$2.87 - $3.94 $26,211 - $35,984	9,133 New	9,133 $28,000
Q4 2021 Feb 14, 2022	SELL	$4.45 - $6.21 $3.56 Million - $4.97 Million	-800,000 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$9.04 - $14.19 $7.23 Million - $11.4 Million	800,000 New	800,000 $8.08 Million

63.9M

2.9K

500

Ticker NAUT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,663,000
Market Cap $324M
Description
Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company was found...

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.